Delivery Order SPE2DB20D1051-SPE2DB24FD6DS
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,296.42, is for the delivery of MOVIPREP powder packets, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 23, 2024. This contract is not associated with a set-aside program....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.37 Firm Fixed Price Delivery Order contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. This award is not designated with a set-aside requirement,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,662.58 firm fixed-price delivery order is for the supply of MOVIPREP powder packets, with a performance period ending on May 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the supply of MOVIPREP powder packets to the Defense Logistics Agency (DLA), a defense agency that provides equipment, supplies, and services to the U.S. military. The $1,960.16 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 19, 2024. This award is a child contract under a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,765.05, is a Firm Fixed Price Delivery Order for the supply of MOVIPREP POWDER PACKETS. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVIPREP POWDER PACKETS. The $3,019.54 firm fixed-price contract has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with...
- This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is for the delivery of MOVIPREP POWDER PACKETS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,483.59 and a completion date of September 26, 2022. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The contract is not designated with a set-aside. It is part of a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.30 firm fixed-price delivery order is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a performance period through July 7, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,300.21 firm-fixed-price delivery order is for MOVIPREP POWDER PACKETS, a medical product. The contract has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a $4,966.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical product, with a completion date of May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD6DSDelivery Order
This federal contract award is for the delivery of MOVIPREP POWDER PACKETS to the Defense Logistics Agency (DLA), a defense agency. The $1,519.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 28, 2023. The contract has a completion date of November 29, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit company registered in the System for Award Management (SAM.gov) and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/28/23 |